Assignee
HALOZYME INC
US·51 granted patents·28 pending applications·925 citations·filing 2001–2025
Top patents by PatentIndex Score
79 records- 0199US7871607B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2005·Granted Jan 18, 2011·128 cites·32 claims
- 0299US7846431B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2010·Granted Dec 7, 2010·89 cites·18 claims
- 0399US7829081B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2010·Granted Nov 9, 2010·92 cites·21 claims
- 0499US7767429B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2004·Granted Aug 3, 2010·250 cites·52 claims
- 0598US11066656B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2020·Granted Jul 20, 2021·30 cites·25 claims
- 0698US11041149B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2020·Granted Jun 22, 2021·32 cites·17 claims
- 0798US10865400B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2016·Granted Dec 15, 2020·25 cites·18 claims
- 0898US10016491B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2015·Granted Jul 10, 2018·28 cites·28 claims
- 0997US12104185B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2024·Granted Oct 1, 2024·2 cites·11 claims
- 1097US12091692B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2021·Granted Sep 17, 2024·3 cites·40 claims
- 1197US12077791B2PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereofHALOZYME INC·Filed 2023·Granted Sep 3, 2024·1 cites·10 claims
- 1297US12018298B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2023·Granted Jun 25, 2024·1 cites·22 claims
- 1397US11952600B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2023·Granted Apr 9, 2024·2 cites·21 claims
- 1497US10588983B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2018·Granted Mar 17, 2020·27 cites·10 claims
- 1597US9211315B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2014·Granted Dec 15, 2015·36 cites·29 claims
- 1697US8343487B2Large-scale production of soluble hyaluronidaseHALOZYME INC·Filed 2012·Granted Jan 1, 2013·48 cites·18 claims
- 1796US10286044B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2017·Granted May 14, 2019·14 cites·22 claims
- 1896US7718428B2Myeloid colony stimulating factor and uses thereofHALOZYME INC·Filed 2006·Granted May 18, 2010·27 cites·3 claims
- 1996US7544499B2Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2003·Granted Jun 9, 2009·49 cites·17 claims
- 2094US12264345B1PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2024·Granted Apr 1, 2025·0 cites·17 claims
- 2193US12195773B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2024·Granted Jan 14, 2025·0 cites·15 claims
- 2293US9562223B2Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)HALOZYME INC·Filed 2014·Granted Feb 7, 2017·10 cites·24 claims
- 2393US2025051747A1Ph20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2024·Application pending·0 cites
- 2492US12037618B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2021·Granted Jul 16, 2024·1 cites·40 claims
- 2592US11723959B2Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptideHALOZYME INC·Filed 2020·Granted Aug 15, 2023·2 cites·13 claims
- 2692US2025154488A1Ph20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2024·Application pending·0 cites
- 2791US10898551B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2019·Granted Jan 26, 2021·2 cites·41 claims
- 2891US10137104B2Combination therapy with an anti-hyaluronan agent and therapeutic agentHALOZYME INC·Filed 2017·Granted Nov 27, 2018·9 cites·30 claims
- 2990US12371685B2PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereofHALOZYME INC·Filed 2023·Granted Jul 29, 2025·0 cites·10 claims
- 3090US12152262B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2023·Granted Nov 26, 2024·0 cites·13 claims
- 3190US2025041521A1Prefilled syringe injectorHALOZYME INC·Filed 2024·Application pending·0 cites
- 3289US2025222078A1Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditionsHALOZYME INC·Filed 2024·Application pending·0 cites
- 3389US2023321203A1SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOFHALOZYME INC·Filed 2023·Application pending·0 cites
- 3488US12123035B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2022·Granted Oct 22, 2024·0 cites·34 claims
- 3588US12110520B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2022·Granted Oct 8, 2024·0 cites·35 claims
- 3688US12104184B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2022·Granted Oct 1, 2024·0 cites·35 claims
- 3788US12060590B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2022·Granted Aug 13, 2024·0 cites·35 claims
- 3888US12054758B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2022·Granted Aug 6, 2024·0 cites·40 claims
- 3988US12049652B2PH20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2022·Granted Jul 30, 2024·0 cites·40 claims
- 4088US2023287381A1Ph20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2022·Application pending·0 cites
- 4184US10265410B2Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effectsHALOZYME INC·Filed 2016·Granted Apr 23, 2019·4 cites·35 claims
- 4282US12551539B2Hyaluronidase enzyme formulations for high volume administrationHALOZYME INC·Filed 2024·Granted Feb 17, 2026·0 cites·20 claims
- 4382US12544429B2Hyaluronidase enzyme formulations for high volume administrationHALOZYME INC·Filed 2024·Granted Feb 10, 2026·0 cites·20 claims
- 4482US2025197835A1Ph20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2025·Application pending·0 cites
- 4582US2025197832A1Ph20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2025·Application pending·0 cites
- 4682US2025197834A1Ph20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2025·Application pending·0 cites
- 4782US2025197833A1Ph20 polypeptide variants, formulations and uses thereofHALOZYME INC·Filed 2025·Application pending·0 cites
- 4880US12558404B2Hyaluronidase enzyme formulations for high volume administrationHALOZYME INC·Filed 2024·Granted Feb 24, 2026·0 cites·15 claims
- 4980US12178860B2Hyaluronidase enzyme formulations for high volume administrationHALOZYME INC·Filed 2023·Granted Dec 31, 2024·0 cites·12 claims
- 5080US7538097B2Inhibition of antigen presentation with poorly catabolized polymersHALOZYME INC·Filed 2001·Granted May 26, 2009·8 cites·9 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when HALOZYME INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →